Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Pharmacovigilance Market Report by Service Provider (In-house, Contract Outsourcing), Product Life Cycle (Pre-clinical, Phase I, Phase II, Phase III, Phase IV), Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), Process Flow (Case Data Management, Signal Detection, Risk Management System), Therapeutic Area (Oncology, Neurology, Cardiology, Respiratory Systems, and Others), End Use (Pharmaceuticals Companies, Biotechnology Companies, Medical Device Companies, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A3609
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmacovigilance Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Service Provider
6.1 In-house
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Contract Outsourcing
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product Life Cycle
7.1 Pre-clinical
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Phase I
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Phase II
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Phase III
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Phase IV
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Type
8.1 Spontaneous Reporting
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Intensified ADR Reporting
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Targeted Spontaneous Reporting
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cohort Event Monitoring
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 EHR Mining
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Process Flow
9.1 Case Data Management
9.1.1 Market Trends
9.1.2 Major Types
9.1.2.1 Case Logging
9.1.2.2 Case Data Analysis
9.1.2.3 Medical Reviewing and Reporting
9.1.3 Market Forecast
9.2 Signal Detection
9.2.1 Market Trends
9.2.2 Major Types
9.2.2.1 Adverse Event Logging
9.2.2.2 Adverse Event Analysis
9.2.2.3 Adverse Event Review and Reporting
9.2.3 Market Forecast
9.3 Risk Management System
9.3.1 Market Trends
9.3.2 Major Types
9.3.2.1 Risk Evaluation System
9.3.2.2 Risk Mitigation System
9.3.3 Market Forecast
10 Market Breakup by Therapeutic Area
10.1 Oncology
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Neurology
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Cardiology
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Respiratory Systems
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by End Use
11.1 Pharmaceuticals Companies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Biotechnology Companies
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Medical Device Companies
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Others
11.4.1 Market Trends
11.4.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Accenture plc
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 ArisGlobal LLC
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.3 BioClinica Inc. (Cinven Partners LLP)
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.3.3 SWOT Analysis
17.3.4 Capgemini
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.5 Cognizant
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 International Business Machines Corporation
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 Financials
17.3.6.4 SWOT Analysis
17.3.7 ICON plc.
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.7.4 SWOT Analysis
17.3.8 IQVIA Inc.
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 ITClinical
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.10 Parexel International Corporation
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.10.3 SWOT Analysis
17.3.11 Wipro Limited
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.11.3 Financials
17.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Pharmacovigilance Market: Major Drivers and Challenges
Figure 2: Global: Pharmacovigilance Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Pharmacovigilance Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Pharmacovigilance Market: Breakup by Service Provider (in %), 2023
Figure 5: Global: Pharmacovigilance Market: Breakup by Product Life Cycle (in %), 2023
Figure 6: Global: Pharmacovigilance Market: Breakup by Type (in %), 2023
Figure 7: Global: Pharmacovigilance Market: Breakup by Process Flow (in %), 2023
Figure 8: Global: Pharmacovigilance Market: Breakup by Therapeutic Area (in %), 2023
Figure 9: Global: Pharmacovigilance Market: Breakup by End Use (in %), 2023
Figure 10: Global: Pharmacovigilance Market: Breakup by Region (in %), 2023
Figure 11: Global: Pharmacovigilance (In-house) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Pharmacovigilance (In-house) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Pharmacovigilance (Contract Outsourcing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Pharmacovigilance (Contract Outsourcing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Pharmacovigilance (Pre-clinical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Pharmacovigilance (Pre-clinical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Pharmacovigilance (Phase I) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Pharmacovigilance (Phase I) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Pharmacovigilance (Phase II) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Pharmacovigilance (Phase II) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Pharmacovigilance (Phase III) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Pharmacovigilance (Phase III) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Pharmacovigilance (Phase IV) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Pharmacovigilance (Phase IV) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Pharmacovigilance (Spontaneous Reporting) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Pharmacovigilance (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Pharmacovigilance (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Pharmacovigilance (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Pharmacovigilance (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Pharmacovigilance (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Pharmacovigilance (EHR Mining) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Pharmacovigilance (EHR Mining) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Pharmacovigilance (Case Data Management) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Pharmacovigilance (Case Data Management) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Pharmacovigilance (Signal Detection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Pharmacovigilance (Signal Detection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Pharmacovigilance (Risk Management System) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Pharmacovigilance (Risk Management System) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Pharmacovigilance (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Pharmacovigilance (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Pharmacovigilance (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Pharmacovigilance (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Pharmacovigilance (Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Pharmacovigilance (Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Global: Pharmacovigilance (Respiratory Systems) Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Global: Pharmacovigilance (Respiratory Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Global: Pharmacovigilance (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Global: Pharmacovigilance (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Global: Pharmacovigilance (Pharmaceuticals Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Global: Pharmacovigilance (Pharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Global: Pharmacovigilance (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Global: Pharmacovigilance (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Global: Pharmacovigilance (Medical Device Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Global: Pharmacovigilance (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Global: Pharmacovigilance (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Global: Pharmacovigilance (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: North America: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: North America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: United States: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: United States: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Canada: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Canada: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Asia-Pacific: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Asia-Pacific: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: China: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: China: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Japan: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Japan: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: India: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: India: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: South Korea: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: South Korea: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Australia: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Australia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Indonesia: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Indonesia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Europe: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Europe: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Germany: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Germany: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: France: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: France: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: United Kingdom: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: United Kingdom: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Italy: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Italy: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Spain: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Spain: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Russia: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Russia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 95: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 96: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 97: Latin America: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 98: Latin America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 99: Brazil: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 100: Brazil: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 101: Mexico: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 102: Mexico: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 103: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 104: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 105: Middle East and Africa: Pharmacovigilance Market: Sales Value (in Million US$), 2018 & 2023
Figure 106: Middle East and Africa: Pharmacovigilance Market: Breakup by Country (in %), 2023
Figure 107: Middle East and Africa: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 108: Global: Pharmacovigilance Industry: SWOT Analysis
Figure 109: Global: Pharmacovigilance Industry: Value Chain Analysis
Figure 110: Global: Pharmacovigilance Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Pharmacovigilance Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Pharmacovigilance Market Forecast: Breakup by Service Provider (in Million US$), 2024-2032
Table 3: Global: Pharmacovigilance Market Forecast: Breakup by Product Life Cycle (in Million US$), 2024-2032
Table 4: Global: Pharmacovigilance Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 5: Global: Pharmacovigilance Market Forecast: Breakup by Process Flow (in Million US$), 2024-2032
Table 6: Global: Pharmacovigilance Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
Table 7: Global: Pharmacovigilance Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 8: Global: Pharmacovigilance Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 9: Global: Pharmacovigilance Market: Competitive Structure
Table 10: Global: Pharmacovigilance Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More